CC
Commodore Capital Portfolio holdings
AUM
$1.42B
This Quarter Return
+51.9%
1 Year Return
+73.3%
3 Year Return
+1,330.82%
5 Year Return
–
10 Year Return
–
AUM
$1.5B
AUM Growth
+$1.5B
(+31%)
Cap. Flow
-$130M
Cap. Flow
% of AUM
-8.68%
Top 10 Holdings %
Top 10 Hldgs %
60.18%
Holding
43
New
11
Increased
11
Reduced
12
Closed
4
Top Buys
| 1 |
MindMed
MNMD
|
$54.8M |
| 2 |
Oric Pharmaceuticals
ORIC
|
$27.5M |
| 3 |
Perspective Therapeutics
CATX
|
$25.1M |
| 4 |
Kyverna Therapeutics
KYTX
|
$22.7M |
| 5 |
Pharvaris
PHVS
|
$21.4M |
Top Sells
| 1 |
Adverum Biotechnologies
ADVM
|
$132M |
| 2 |
Vera Therapeutics
VERA
|
$98.5M |
| 3 |
RYZB
RayzeBio, Inc. Common Stock
RYZB
|
$23.9M |
| 4 |
Soleno Therapeutics
SLNO
|
$22.7M |
| 5 |
Rhythm Pharmaceuticals
RYTM
|
$21.7M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Apogee Therapeutics
APGE
$2.17B
| $19.3M | 1.29% |
290,000
+40,000
| +16% | +$2.66M |
|
27
Cabaletta Bio
CABA
$133M
| $18.8M | 1.25% |
1,100,000
-800,000
| -42% | -$13.6M |
|
|
AUTL
28
Autolus Therapeutics
AUTL
$399M
| $14.7M | 0.98% |
+2,300,000
| New | +$14.7M |
|
|
THRD
29
DELISTED
Third Harmonic Bio
THRD
| $11.8M | 0.79% |
1,250,000
+543,294
| +77% | +$5.13M |
|
30
Neurogene
NGNE
$264M
| $10.2M | 0.68% |
+200,000
| New | +$10.2M |
|
|
31
Adverum Biotechnologies
ADVM
$64.6M
| $9.29M | 0.62% |
657,333
-9,342,667
| -93% | -$132M |
|
32
VistaGen Therapeutics
VTGN
$102M
| $8.32M | 0.56% |
1,575,000
| – | – |
|
33
Syndax Pharmaceuticals
SNDX
$1.41B
| $7.59M | 0.51% |
+318,851
| New | +$7.59M |
|
|
34
Soleno Therapeutics
SLNO
$3.6B
| $7.26M | 0.49% |
169,533
-530,467
| -76% | -$22.7M |
|
|
BBOT
35
BridgeBio Oncology Therapeutics, Inc. Common Stock
BBOT
$708M
| $5.2M | 0.35% |
+500,000
| New | +$5.2M |
|
36
MacroGenics
MGNX
$112M
| $4.34M | 0.29% |
+295,020
| New | +$4.34M |
|
37
Adicet Bio
ACET
$59.9M
| $3.23M | 0.22% |
+1,374,320
| New | +$3.23M |
|
38
SAB Biotherapeutics
SABS
$19.3M
| $832K | 0.06% |
183,174
-1,648,572
| -90% | -$7.48M |
|
|
DBVT
39
DBV Technologies
DBVT
$264M
| $69.4K | ﹤0.01% |
92,687
| – | – |
|
40
Akero Therapeutics
AKRO
$3.74B
| – | – |
-565,000
| Closed | -$13.2M |
|
41
Dyne Therapeutics
DYN
$1.92B
| – | – |
-900,000
| Closed | -$12M |
|
|
RYZB
42
DELISTED
RayzeBio, Inc. Common Stock
RYZB
| – | – |
-383,638
| Closed | -$23.9M |
|
|
HARP
43
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
| – | – |
-1,500,000
| Closed | -$17.1M |
|